The Case | A paraneoplastic kidney injury?
Kidney Int
.
2023 Aug;104(2):401-402.
doi: 10.1016/j.kint.2023.05.017.
Authors
Lucile Duvaltier
1
,
Khalil El Karoui
1
,
Nelly Bosselut
2
,
Arnaud Boutan-Laroze
3
,
Jean-Jacques Boffa
1
,
David Buob
4
,
Romain Brousse
5
Affiliations
1
Sorbonne Université, INSERM UMRS 1155, Nephrology Department, Assistance Publique Hôpitaux de Paris, Hôpital Tenon, Paris, France.
2
Université Paris Cité, Department of Cellular Biology, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
3
Department of Medical Oncology, Centre Hospitalier de Bligny, Bligny, France.
4
Sorbonne Université, Department of Pathology, Assistance Publique Hôpitaux de Paris, Hôpital Tenon, Paris, France.
5
Sorbonne Université, INSERM UMRS 1155, Nephrology Department, Assistance Publique Hôpitaux de Paris, Hôpital Tenon, Paris, France. Electronic address: romain.brousse@aphp.fr.
PMID:
37479389
DOI:
10.1016/j.kint.2023.05.017
No abstract available
MeSH terms
Autoantibodies
Humans
Kidney / diagnostic imaging
Kidney Neoplasms* / complications
Kidney Neoplasms* / diagnosis
Paraneoplastic Syndromes* / diagnosis
Paraneoplastic Syndromes* / etiology
Substances
Autoantibodies